
IHC of formalin-fixed, paraffin-embedded human breast tissue using LS-C148259 at 1:2000. A, normal breast tissue. B, ductal carcinoma in situ (DCIS). C, invasive breast carcinoma. A1, B1, and C1 are higher magnifications of A, B and C, respectively. Hematoxylin-Eos in counterstain. IncreasedcIAP1 expression is seen in the cancerous compared to normal breast tissue. Hematoxylin-Eos in counterstain.

IHC of a formalin-fixed, paraffin-embedded human ovarian cancer tissue microarray using LS-C148259 at 1:2000. Differential expression of cIAP1 is seen between patient samples. Hematoxylin-Eosin counterstain.